Vaxess Technologies to develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
On Sept. 14, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…
On Sept. 9, 2020, the National Institutes of Health (NIH) announced that after nearly 15 years on an…
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
On Sept. 2, 2020, Aegis Sciences annunced that it had been selected to participate in the National Institutes…
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
On Sept. 2, 2020, Ceres Nanosciences announced it had been awarded a contract from the National Institutes of…
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…